AGN News and Press, Allergan plc From 02/04/20

Source (Shutterstock/Liya Graphics) Introduction Gilead Sciences ( GILD ) was positioned to be the poster child of Trump's plan to eradicate HIV, as outlined in my previous article . Like almost all outbreaks including the Wuhan coronavirus, the only effective way to complete...

Introduction Every week, I try to find the five most opportunistic and timely dividend stocks to highlight as "buy" ideas and present them in these articles. There are many dividend stock "listicles" (list articles) on the Internet, but relatively few of them focus solely on stocks that are ...

Major market benchmarks hit new highs in early 2020 as a wave of optimism swept over the market. But sentiment can turn sharply at any moment, as investors are seeing recently with worries about the coronavirus outbreak, and conservative investors may be wondering whether it's worth the risk to ...

DUBLIN , Feb. 3, 2020 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced today its Be The Difference philanthropic program supporting children and their families who may benefit from treatment with BOTOX ® (onabotulinumtoxinA) for pediatric upper limb spasticity. BOTOX ®...

Eli Lilly (NYSE: LLY) launched its new pill for the acute treatment of migraines Friday after the Drug Enforcement Administration  completed its review of the drug and classified it as having a low potential for abuse or dependence. Reyvow is the first drug of a new class, and treats no...

DUBLIN , Jan. 31, 2020 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced it will release fourth quarter and full year 2019 financial results on Monday, February 10, 2020 , prior to the open of U.S. financial markets. For additional materials related to Allergan's fourth q...

DUBLIN , Jan. 30, 2020 /PRNewswire/ --  NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION In accordance with Rule 2.1...

CTFN is out with a story that Allergan ( AGN ) circulated employee communication indicating an early February close of its AbbVie (ABBV) deal. This is not incongruent with existing information but if accepted as a fact decreases the time-to-close the likely timeline to a close from 20-40 d...

Privately held regenerative medicine firm Histogen announces that it has granted exclusive rights to collaboration partner Allergan ( AGN -0.8% ) to incorporate and commercialize its cell conditioned media (CCM) technology in microabrasion therapies and new Histogen intellectual proper...

Some unlikely good Samaritans are going out of their way to help AbbVie (NYSE: ABBV) and Allergan   (NYSE: AGN) complete the $63 billion merger deal the giant drugmakers announced last June. To appease antitrust regulators,  AstraZeneca   (NYSE: AZN) will take back control ...